Hoitt Jason

CIK 00017625723 companiesBEDFORD, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001762572

Recent Transactions

33 trades

Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2026-03-18$31.28/sh−1,762→ 10,445 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2026-03-18$31.79/sh−139→ 10,306 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2026-03-18$32.85/sh−30→ 10,276 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2026-03-17$33.38/sh−748→ 12,207 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2026-03-17$32.74/sh−1,033→ 12,955 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2026-03-15−10,000→ 30,000 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2026-03-15+10,000→ 13,988 total
Award
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2026-02-17+48,000→ 48,000 total
Award
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2026-02-17+72,000→ 72,000 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−139,500→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−145,000→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−400,000→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−200,000→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−137,750→ 0 total
Sale
Provention Bio, Inc.
Common Stock
2023-02-10$10.00/sh−4,500→ 0 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2023-01-10+200,000→ 200,000 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2022-12-08+20,663→ 75,763 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2022-12-08+120,000→ 340,000 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2022-01-18+145,000→ 145,000 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2021-05-12+139,500→ 139,500 total
Award
Provention Bio, Inc.
Option (right to buy)
2020-07-15+137,750→ 137,750 total
Purchase
Provention Bio, Inc.
Common Stock
2020-03-19$5.43/sh+4,500→ 4,500 total
Award
Provention Bio, Inc.
Option (right to buy)
2020-01-07+400,000→ 400,000 total
Disposition to Issuer
Dova Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
2019-11-12−250,000→ 0 total
Disposition to Issuer
Dova Pharmaceuticals Inc.
Common Stock
2019-11-12−9,970→ 0 total
Sale
Dova Pharmaceuticals Inc.
Common Stock
2019-09-30$28.00/sh−2,387→ 9,970 total
Sale
Dova Pharmaceuticals Inc.
Common Stock
2019-07-15$15.10/sh−6,680→ 13,257 total
Sale
Dova Pharmaceuticals Inc.
Common Stock
2019-07-15$16.44/sh−900→ 12,357 total
Sale
Dova Pharmaceuticals Inc.
Common Stock
2019-06-28$13.77/sh−2,237→ 20,087 total
Sale
Dova Pharmaceuticals Inc.
Common Stock
2019-06-28$14.40/sh−150→ 19,937 total
Sale
Dova Pharmaceuticals Inc.
Common Stock
2019-04-08$8.77/sh−2,387→ 22,324 total
Award
Dova Pharmaceuticals Inc.
Common Stock
2018-12-19+24,711→ 24,711 total
Award
Dova Pharmaceuticals Inc.
Employee Stock Option (right to buy)
2018-12-19+250,000→ 250,000 total

Companies

Recent Filings

Address

C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE

BEDFORD, MA, 01730

View on SEC.gov